Cipla
Jaco Coetzee has extensive experience in the pharmaceutical industry, currently serving as the Head of Rx Sales, Marketing, and Operations at Cipla since September 2008. In this role, Jaco oversees the Rx Sales portfolio for Cipla South Africa and the One Africa region, driving sales effectiveness and training initiatives. Previously, Jaco held several leadership positions at Cipla, including Head of South Africa Rx Sales, where responsibilities included managing Rx and OTC Commercial Excellence and leading a sales force focused on market share growth. Prior to Cipla, Jaco was self-employed as an optometrist and worked as a Branch Manager at Mellin & Partners, demonstrating a solid background in both sales and healthcare. Jaco holds an MBA from Stellenbosch University and a B. Optometry from the University of Johannesburg.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.